IL2RA and type 1 diabetes mellitus: These findings complement a previous report that baseline frequencies of antiinflammatory CD4+CD25+CD127hi T cells at T1D diagnosis are correlated with a favorable response to alefacept (21) and may indicate that response to therapy is linked to the balance of proinflammatory autoreactive cells with this antiinflammatory cell population.